Drawing for CT EXPRÈS

USPTO serial 79001741

CT EXPRÈS

Reviewed by CopyMark Law Group

Reg. 2965374Status 739Registered
Filing date
Status date
Registration date
Jul 5, 2005
Examiner
MCCRAY, RENEE
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with CT EXPRÈS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010Apparatus for dispensing medicines and substances for medical and veterinary use, injectors for contrast products in the field of medical and/or diagnostic imagery, devices for the sustained release of medicines and devices for programmable dispensing of medicines through the skin, namely, programmable implantable pumps, single-use medical or veterinary programmable pumps, pumps with cartridges for dispensing medicines and pharmaceuticals or veterinary substancesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 20, 2025NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jul 20, 2025C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Jul 14, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 7, 2025ES75TEAS SECTION 71 & 15 RECEIVED
Aug 6, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 6, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 6, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 5, 2024REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Dec 14, 2023RNWLINTERNATIONAL REGISTRATION RENEWED
Jul 20, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 20, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 20, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 1, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED
Apr 22, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED
Feb 2, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 2, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 2, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 2, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 2, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 2, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 27, 2021CHLDCHANGE OF OWNER RECEIVED FROM IB
Nov 8, 2018ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
May 23, 2017CORVREVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Jan 31, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 29, 2015NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jul 27, 2015NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jul 27, 201571AGREGISTERED-SEC.71 ACCEPTED
Jul 27, 2015APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 30, 2015ES71TEAS SECTION 71 RECEIVED
Feb 17, 2014RNWLINTERNATIONAL REGISTRATION RENEWED
Mar 22, 2013ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 30, 2012NREPNEW REPRESENTATIVE AT IB RECEIVED
Sep 23, 2011NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Sep 23, 2011NA15SEC. 15 ACKNOWLEDGEMENT - E-MAILED
Sep 23, 201115AKREGISTERED - SEC. 15 ACKNOWLEDGED
Sep 23, 201171AGREGISTERED-SEC.71 ACCEPTED
Sep 11, 2011EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Aug 5, 2011CHLDCHANGE OF OWNER RECEIVED FROM IB
Jul 29, 2011PR71POST REGISTRATION ACTION MAILED - SEC.71
Jul 5, 2011APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 4, 2011E15RTEAS SECTION 15 RECEIVED
Jul 4, 2011ES71TEAS SECTION 71 RECEIVED
Sep 6, 2007FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Apr 21, 2006FISNFINAL DECISION PROCESSED AND SENT TO IB
Jul 5, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 9, 2005TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 12, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 23, 2005NPUBNOTICE OF PUBLICATION
Jan 10, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 7, 2005ALIEASSIGNED TO LIE
Jan 1, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Dec 22, 2004ACECAMENDMENT FROM APPLICANT ENTERED
Dec 8, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 8, 2004MAILPAPER RECEIVED
Oct 7, 2004RFNTREFUSAL PROCESSED BY IB
Sep 8, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 16, 2004DOCKASSIGNED TO EXAMINER
Apr 28, 2004NWAPNEW APPLICATION ENTERED
Apr 23, 2004REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance